Gene · 64783
RBM15: RNA binding motif protein 15
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. RBM15: RNA binding motif protein 15. Genes, record 64783. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/64783
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q96T37 | RNA-binding protein 15 | 977 | 2 | Ensembl, GeneID, HGNC |
Source UniProt
Patents21
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 62381 | Q96T37 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 8669 | Q96T37 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 8859 | Q96T37 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 8859 | Q96T37 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 8669 | Q96T37 | Espacenet |
| US 12023371 B2 | 2024-07-02 | 4728 | Q96T37 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 75189 | Q96T37 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 75193 | Q96T37 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 178160 | Q96T37 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 178164 | Q96T37 | Espacenet |
1 to 10 of 21
See all 21 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants743
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | RBM15 papers | Newest fiscal year |
|---|---|---|---|
| P30CA021765 | Cancer Center Support Grant (CCSG) | 10 | 2025 |
| ZIASC010357 | Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses | 7 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 6 | 2025 |
| RM1HG008935 | Center for dynamic RNA epitranscriptomes - Renewal | 6 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 5 | 2025 |
| ZIABC010334 | Conserved Element DNA Vaccine | 5 | 2025 |
| R01CA186702 | Mechanisms of epitranscriptomic regulation in cancer | 4 | 2025 |
| R01CA096512 | Cell model for KSHV infection and genetic manipulation | 3 | 2025 |
| R01CA124332 | Regulation of KSHV replication by N6-methyladenosine (m6A) | 3 | 2025 |
| R01CA271497 | The role and therapeutic potential of IGF2BP2 in MLL-rearranged leukemia | 3 | 2025 |
1 to 10 of 743Source NIH's project files
See all 743 nih grantsPapers2,224
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| RNA m⁶A modification and its regulatory factors are altered in granulosa cells from women with PMOS. | J Assist Reprod Genet | 2026 | 42687053 | PubTator, text mining | PubMed |
| RBM15 in leukemogenesis: an emerging regulator at the interface of RNA biology and hematopoiesis. | Trends Cancer | 2026 | 42680676 | PubTator, text mining | PubMed |
| PTBP1 controls oncogenic transcript processing and maintenance of acute myeloid leukemia. | Leukemia | 2026 | 42637878 | PubTator, text mining | PubMed |
| ZBTB33/RBM15 Axis Upregulates MACC1 to Promote the Malignant Progression of Colorectal Cancer. | Curr Gene Ther | 2026 | 42634545 | PubTator, text mining | PubMed |
| Integrative single-cell transcriptomic and epitranscriptomic analysis of the RBM15-m6A-IL10 regulatory axis in psoriatic keratinocytes. | Front Cell Dev Biol | 2026 | 42614367 | PubTator, text mining | PubMed |
| m6A-dependent regulation of DGUOK-AS1 by RBM15 and HNRNPH1 in lung adenocarcinoma. | iScience | 2026 | 42603931 | PubTator, text mining | PubMed |
| The N6-Methyladenosine-Modified CIT Promotes Uterine Corpus Endometrial Carcinoma Progression by Inhibiting the Hippo Signaling Pathway. | Immunol Cell Biol | 2026 | 42565639 | PubTator, text mining | PubMed |
| Global Phosphoproteome Analysis Identifies CLK4 Co-Regulatory Pathways Driving Tumor-Specific Dysregulation. | OMICS | 2026 | 42484065 | PubTator, text mining | PubMed |
| RBM15 plays a key driving role in the tumorigenesis of EGFR-mutant lung adenocarcinoma and gefitinib resistance. | Sci Rep | 2026 | 42426119 | PubTator, text mining | PubMed |
| RBM15 enhances ILDR1 n6-methyladenosine methylation to accelerate gastric adenocarcinoma progression via an IGF2BP3-dependent manner. | Cytotechnology | 2026 | 42404851 | PubTator, text mining | PubMed |
1 to 10 of 2,224
See all 2,224 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/64783
GET https://conductscience.org/api/genes/v1/64783/patents?page=2